Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair loss is not listed as a common side effect of Mounjaro (tirzepatide) in its official UK prescribing information, but some people do report noticeable shedding during the first months of treatment. The likely cause is a well-understood biological process called telogen effluvium — temporary shedding triggered by rapid weight loss itself, not the medicine directly. Understanding the difference matters, because it affects how you respond and what you can realistically expect. These are prescription-only medicines, and any concerns about side effects are exactly the kind of thing a prescriber should know about. The NHS tirzepatide patient information page does not list hair loss among the recognised effects of tirzepatide, which is consistent with the clinical trial data and the medicine's Summary of Product Characteristics on the eMC.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Looking through the SURMOUNT-1 trial data and the Mounjaro SmPC, hair loss does not appear in the list of common or uncommon adverse reactions. That is important context, because tens of thousands of doses were given across the SURMOUNT clinical programme, if tirzepatide itself were reliably causing hair loss at a meaningful rate, the pharmacovigilance system would have flagged it as a labelled effect. It has not. The answer to whether Mounjaro directly causes hair loss is therefore: probably not, based on current evidence.
What the data does show is that significant, sustained weight loss (of any kind) is associated with temporary hair shedding. In SURMOUNT-1, participants lost an average of around 20% of their body weight over 72 weeks at the highest dose. That degree of physiological change is, on its own, a known trigger for the hair-shedding response. So the medicine may be the reason weight loss is happening, but that is not quite the same thing as the medicine attacking your hair follicles.
If you want a fuller picture of how Mounjaro works and the full side-effect profile, the Mounjaro side effects guide covers the complete list of recognised effects alongside the less common ones worth knowing about.
Hair follicles cycle through growth, transition and rest phases. Physical stress (surgery, illness, a crash diet, or sustained rapid weight loss) can push an unusually large number of follicles into the resting phase simultaneously. Two to four months later, those resting hairs fall out together. This is telogen effluvium, and it looks alarming in the shower, but the follicles themselves are intact. They grow back.
The shedding tends to peak and then slow as weight stabilises. Nutritional factors can extend or worsen it: low protein intake is a particular culprit, because the body deprioritises non-essential protein use (including hair production) when intake drops. Iron deficiency, low ferritin, zinc and certain B vitamins are also implicated. People taking GLP-1 medicines sometimes eat significantly less than before, and if that reduced intake is also lower in protein or micronutrients, the hair cycle takes longer to normalise.
This is one reason why the lifestyle guidance that comes with Mounjaro treatment consistently emphasises protein adequacy, not just for muscle preservation, but for this kind of knock-on effect. Our clinical team at nume regularly fields questions about this in aftercare, and nutrition support is part of the conversation from the start.
Honesty requires acknowledging that post-marketing surveillance continues for all medicines, particularly those (like Mounjaro) still under additional MHRA monitoring as a Black Triangle (▼) product. Some people report hair changes that feel disproportionate to the amount of weight lost, or that start very early in treatment before significant weight reduction has occurred, and our guide to why Mounjaro causes hair loss looks at the possible mechanisms behind those early or unexpected cases. It is possible that, in a small number of individuals, a mechanism beyond telogen effluvium is at play.
That possibility is worth flagging to your prescriber rather than dismissing. The MHRA's Yellow Card scheme exists precisely for this: if you experience something you think might be a side effect of Mounjaro, reporting it helps regulators build a more complete picture of how the medicine behaves across a real-world population. You do not need to be certain it is the medicine, suspicion is enough to report. Your prescriber can also review whether any other medicines or underlying conditions might be contributing.
There is a broader look at Mounjaro's evidence base and how it is used in the UK on the Mounjaro overview page.
For most people, the hair shedding associated with weight loss resolves on its own and does not need medical intervention beyond nutritional attention, though our detailed page on Mounjaro and hair loss covers the practical steps you can take to support regrowth while you wait. There are situations, though, where you should contact your prescriber or GP promptly rather than waiting it out.
Seek advice if: the shedding is severe or accelerating rather than gradually slowing; you notice patchy loss rather than diffuse thinning (which can indicate a separate condition such as alopecia areata); shedding is accompanied by other new symptoms such as fatigue, cold intolerance or significant mood changes (which can point to thyroid changes, occasionally triggered by major weight shifts); or the loss persists well beyond six months with no sign of regrowth.
Urgent medical help is needed (separately from hair concerns) if you develop severe or persistent stomach pain that radiates to your back (a potential sign of pancreatitis), symptoms of a serious allergic reaction, or any side effect that feels acute and worsening. Those warrant calling 111 or going to A&E, not waiting for an aftercare appointment. For questions about the specific ways hair changes can affect women on this treatment, our page exploring whether Mounjaro causes hair loss in females goes into more detail on hormonal factors that can be at play.
If you are considering starting treatment and want to talk through any of this beforehand, our prescribers cover side effects, suitability and nutrition as part of every consultation. You can start your free consultation here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.